Main Street Group’s Amedisys AMED Stock Holding History

Main Street Group’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-187	Closed	-$17.2K	–	877
2024 Q1	$17.2K	Buy	+187	New	+$17.5K	0.01%	450

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Main Street Group's AMED Position: Q2 2024 in Review

Main Street Group sold out of Amedisys (AMED) in Q2 2024, closing a stake of 187 shares — an estimated $17.2K sold.

Main Street Group first reported a position in AMED in Q1 2024 and held it in 1 quarter. The position peaked at $17.2K in Q1 2024. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

Main Street Group reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
Main Street Group sold 187 Amedisys shares in Q2 2024, an estimated $17.2K.
Main Street Group first reported a position in Amedisys in Q1 2024 and held it in 1 quarter.
Main Street Group's Amedisys position peaked at $17.2K in Q1 2024.
288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Main Street Group's 13F filing for Q2 2024, filed 6 Aug 2024.